DIBBS #SPE2DP-26-T-4476

DLA Solicitation for Moxifloxacin Hydrochloride Tablets (400 mg, 30-count) from Approved OEMs

The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain Pharmacy FSA is soliciting Moxifloxacin Hydrochloride Tablets for Navy use. - Government Buyer: - Defense Logistics Agency (DLA) - Sub-agency: DLA Troop Support Medical Supply Chain Pharmacy FSA - OEMs (Original Equipment Manufacturers): - TEVA PHARMACEUTICALS USA, INC. - RISING PHARMA HOLDINGS, INC. - Products Requested: - Moxifloxacin Hydrochloride Tablets, 400 mg, 30 tablets per bottle - NSN: 6505-01-503-4772 - Part Numbers: NDC00093-7387-56 (TEVA), NDC57237-0156-30 (RISING PHARMA) - Quantity: 24 bottles - Notable Requirements: - Only FDA-regulated, pharmaceutical-grade Moxifloxacin Hydrochloride from approved OEMs is acceptable - Delivery required within 20 days to Navy Expeditionary Central Facility, Williamsburg, VA - Packaging must comply with DLA and Medical Marking Standard No. 1A, MIL-STD-129 - Compliance with domestic sourcing laws and prohibitions on covered defense telecommunications equipment is mandatory

Description

MOXIFLOXACIN HYDROC (QTY: 24, NSN: 6505-01-503-4772, Purchase Request: 7006183184) Approved Sources: - CAGE: 3V8D7, Part No: NDC00093-7387-56, Company: TEVA PHARMACEUTICALS USA, INC. - CAGE: 8FG82, Part No: NDC57237-0156-30, Company: RISING PHARMA HOLDINGS, INC.

View original listing